Anti-TNF sheep monoclonal antibody - KS Biomedix Holdings

Drug Profile

Anti-TNF sheep monoclonal antibody - KS Biomedix Holdings

Latest Information Update: 27 Sep 2002

Price : $50

At a glance

  • Originator KS Biomedix Holdings
  • Class Monoclonal antibodies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Crohn's disease; Septic shock

Most Recent Events

  • 27 Sep 2002 Discontinued - Preclinical for Septic shock in United Kingdom (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for Crohn's disease in United Kingdom (unspecified route)
  • 27 Sep 2002 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top